(Q44380825)

2 December 2017

Thyroxine-derivatives of lipopeptides: bifunctional dimerization inhibitors of human immunodeficiency virus-1 protease (English)

1 reference

2 December 2017

Julien Dumond

1

1 reference

2 December 2017

Nicole Boggetto

2

1 reference

2 December 2017

Hans J Schramm

3

1 reference

2 December 2017

Wolfgang Schramm

4

1 reference

2 December 2017

Masayuki Takahashi

5

1 reference

2 December 2017

Michèle Reboud-Ravaux

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

Biochemical Pharmacology

1 reference

2 December 2017

65

1 reference

2 December 2017

1097-1102

1 reference

2 December 2017

7

1 reference

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Structure-based inhibitors of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

The structural stability of the HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

HIV-1 reproduction is inhibited by peptides derived frm the N- and C-termini of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

The inhibition of human immunodeficiency virus proteases by 'interface peptides'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Lipopeptides as dimerization inhibitors of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Targeting the dimerization interface for irreversible inhibition of HIV-1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Design and synthesis of new inhibitors of HIV-1 protease dimerization with conformationally constrained templates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Use of experimental models for the study of collagen degradation by macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Genetic selection for dissociative inhibitors of designated protein-protein interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Intravirion display of a peptide corresponding to the dimer structure of protease attenuates HIV-1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

HIV protease as a target for retrovirus vector-mediated gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Antagonists of protein-protein interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Modulation of the oligomeric structures of HIV-1 retroviral enzymes by synthetic peptides and small molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Design of dimerization inhibitors of HIV-1 aspartic proteinase: a computer-based combinatorial approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901622-2

10.1016/S0006-2952(02)01622-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference